Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study

Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study

When the dose of conventional disease-modifying anti-rheumatic drugs (cDMARDs) is tapered in rheumatoid arthritis (RA) patients who achieve sustained remission, biomarkers for predicting disease relapse may be needed. A prospective, unblinded cohort study was conducted in nine RA patients with remis...

Full description

Bibliographic Details
Main Authors: Korawit Kanjana, Parawee Chevaisrakul, Ponpan Matangkasombut, Karan Paisooksantivatana, Putthapoom Lumjiaktase
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Medicine
Subjects:
DMARD reduction
Foxp3+Treg
regulatory T cell
biomarkers
prognostic marker
rheumatoid arthritis
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00025/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2020.00025/full

Similar Items